Author | Hyung L. Kim, MD | OncLive

Author | Hyung L. Kim, MD


Dr. Kim Discusses Cytoreductive Nephrectomy in Metastatic RCC

March 07, 2018

Hyung L. Kim, MD, Medallion Group Chair in Urology, co-medical director of the Urologic Oncology Center, associate director, Surgical Research in the Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center, discusses cytoreductive nephrectomy in patients with metastatic renal cell carcinoma.